Status:
COMPLETED
Impact of Esmya on Fertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques
Lead Sponsor:
ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
Collaborating Sponsors:
Gedeon Richter Plc.
Conditions:
Infertility, Female
Fibroid Uterus
Eligibility:
FEMALE
18-43 years
Brief Summary
Fibroid is a frequent pathology of infertile women. Its deleterious effect on the infertility would be due to the mechanical way. The interest of the resection of intramural fibroids is discussed. It...
Detailed Description
A retrospective, national, multicenter study
Eligibility Criteria
Inclusion
- Age between 18 to 43 years 'old at the time of the beginning of ulipristal acetate intake
- Women with fibroid at the time of ulipristal acetate prescription
- Women with desire to have children and managed for infertility in an ART center (whatever the type of infertility treatment)
- Women having received a treatment by ulipristal acetate
- Data collected between 2013/12/01 and 2018/06/30 ; data collected between ulipristal acetate prescription until the term of pregnancy or embryo transfer failure (up to 4) or death/lost to follow up or ART treatment discontinuation
Exclusion
- none
Key Trial Info
Start Date :
December 29 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 8 2019
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT03349190
Start Date
December 29 2017
End Date
January 8 2019
Last Update
January 9 2019
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Angers
Angers, France
2
Chu Besancon
Besançon, France
3
Chu Pellegrin
Bordeaux, France
4
Polyclinique Jean Villar
Bruges, France